Fig. 4From: Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effectsMRI imaging of patient 2 displaying disease activity. a FLAIR and b T1 weighted MRI with application of gadolinium at day 300 after start of ATRA revealed multiple gadolinium-enhancing lesionsBack to article page